Michael Lee Milligan
Title: Chief Financial Officer & Principal Accounting Officer · Neumora Therapeutics, Inc.
- 2026
- Aug 21, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Lee Milligan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ARCH Venture Partners X, LLC - $5.00M in NMRA purchases and sales in the last 12 months
- ARCH Venture Partners XII, LLC - $5.00M in NMRA purchases and sales in the last 12 months
- Kristina Burow - $5.00M in NMRA purchases and sales in the last 12 months
- Daljit Singh Aurora - $1.03M in NMRA purchases and sales in the last 12 months
- Paul L. Berns - $34K in NMRA purchases and sales in the last 12 months
- Joshua Pinto - $21K in NMRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Lee Milligan?
Michael Lee Milligan is a corporate insider, tracked as Title: Chief Financial Officer & Principal Accounting Officer of Neumora Therapeutics, Inc. (NMRA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael Lee Milligan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Michael Lee Milligan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($5K) across all tracked filings.
